Perna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, . . . Rondanelli M. (2018). 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus. Dove Medical Press.
Chicago Style (17th ed.) CitationPerna S, Mainardi M, Astrone P, Gozzer C, Biava A, Bacchio R, Spadaccini D, Solerte SB, and Rondanelli M. 12-month Effects of Incretins Versus SGLT2-Inhibitors on Cognitive Performance and Metabolic Profile. A Randomized Clinical Trial in the Elderly with Type-2 Diabetes Mellitus. Dove Medical Press, 2018.
MLA (9th ed.) CitationPerna S, et al. 12-month Effects of Incretins Versus SGLT2-Inhibitors on Cognitive Performance and Metabolic Profile. A Randomized Clinical Trial in the Elderly with Type-2 Diabetes Mellitus. Dove Medical Press, 2018.